Your browser doesn't support javascript.
loading
Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function.
Long, Tiha M; Nisa, Shahista; Donnenberg, Michael S; Hassel, Bret A.
Afiliação
  • Long TM; Graduate Program in Molecular Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Nisa S; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Donnenberg MS; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Hassel BA; Graduate Program in Molecular Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland, USA Department of Microbiology and Immunology, University of Maryland School of Me
Infect Immun ; 82(7): 2802-14, 2014 Jul.
Article em En | MEDLINE | ID: mdl-24733098
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon beta / Endorribonucleases / Escherichia coli Enteropatogênica / Mucosa Intestinal Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Infect Immun Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon beta / Endorribonucleases / Escherichia coli Enteropatogênica / Mucosa Intestinal Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Infect Immun Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos